在大比加特朗与伊达鲁齐祖马布逆转治疗大出血期间的声波测量参数
Dorian Teissandier1, Geoffroy Rousseau2, Camille Lucchini3
1Emergency Department, Centre hospitalier universitaire Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, Institut national de recherche pour l'agriculture, l'alimentation et l'environnement, Unité de Nutrition humaine, Unité de Nutrition Humaine, Centre de recherche en Nutrition humaine Auvergne, Clermont-Ferrand, France.
概括
粘性弹性血静性试验 (VHA) 在严重出血患者中有效监测了达比加特兰与伊达鲁齐祖马布的逆转. VHA显示凝血改善,证实了idarucizumab的存在.
科学领域:
- 血液学 血液学 血液学
- 临床凝血 临床凝血
- 诊断检测试验 诊断检测试验
背景情况:
- 在服用口服抗凝剂的患者中,在出血期间监测凝血是具有挑战性的.
- 专家指南存在,但在重大出血事件期间实时评估需要有效的工具.
- 达比加特兰逆转药物,如伊达鲁齐祖马布,需要可靠的方法来确认有效性.
研究的目的:
- 评估使用Quantra分析仪对用大比加特兰治疗的大型出血的患者进行粘弹性静血试验 (VHA) 的有用性.
- 通过对VHA监测凝血参数来评估idarucizumab逆转疗法的有效性.
- 确定VHA是否可以准确地反映达比加的存在及其逆转的成功.
主要方法:
- 一项前性多中心研究,涉及6名接受达比加特兰治疗的患者,这些患者有国际血栓学会和血液静止学会的大型出血.
- 血液样本在紧急住院和idarucizumab管理后30分钟使用Quantra分析仪进行分析.
- 测量了关键的VHA参数,包括凝血时间 (CT),肝激酶凝血时间 (CTH) 和凝血刚度 (CS).
主要成果:
- 在idarucizumab治疗前,VHA表明低凝血状态,CT和CTH持续时间长,CS低.
- 在idarucizumab给药后,CT和CTH显著下降 (P = .002),而CS显著增加 (P = .03),恢复到正常范围.
- 反IIa活性中位数在逆转后30分钟内下降至30ng/mL以下,在24小时内持续下降 (P = .0008).
结论:
- 使用Quantra分析仪进行粘性弹性静血测定 (VHA) 对于评估达比加特兰的存在和监测大出血中伊达鲁齐祖马布的逆转疗效非常有价值.
- VHA在凝血参数中显著改善,证实了伊达鲁齐祖马布在恢复血液静止方面的有效性.
- 这些发现支持在与达比加特兰相关的重大出血事件的临床管理中使用VHA.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
01:29Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28